Longboard Asset Management, LP Gilead Sciences, Inc. Transaction History
Longboard Asset Management, LP
- $61.9 Billion
- Q3 2025
A detailed history of Longboard Asset Management, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Longboard Asset Management, LP holds 2,205 shares of GILD stock, worth $270,244. This represents 0.4% of its overall portfolio holdings.
Number of Shares
2,205
Previous 2,205
-0.0%
Holding current value
$270,244
Previous $244 Million
0.12%
% of portfolio
0.4%
Previous 0.61%
Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,366Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.06M-
Black Rock Inc. New York, NY121MShares$14.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.6 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.25 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.67 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.6 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $154B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...